Medicare Enrolled
Dr. Kalpesh Solanki, DO
Cardiovascular Disease · Ocala, FL
Practice pattern: Electrophysiology & Cardiac— Practice combining electrophysiology and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Solanki from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Solanki? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Solanki
Dr. Kalpesh Solanki is a cardiovascular disease in Ocala, FL, with 19 years in practice. Based on federal Medicare data, Dr. Solanki performed 8,903 Medicare services across 4,779 unique beneficiaries.
Between the years covered by Open Payments, Dr. Solanki received a total of $23,233 from 50 pharmaceutical and/or device companies across 645 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Solanki is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 9% volume in FL$ $23,233 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,903
Medicare services
Top 9% in FL for cardiovascular disease
4,779
Unique beneficiaries
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~469 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 1,860 | $0 | $0 |
| Office visit, established patient (20-29 min) | 796 | $65 | $164 |
| Regadenoson injection (Lexiscan) for heart stress test | 644 | $42 | $108 |
| Office visit, established patient (30-39 min) | 618 | $93 | $233 |
| Electrocardiogram (EKG), 12-lead | 605 | $10 | $36 |
| Remote pacemaker/defibrillator monitoring, 90 days | 331 | $14 | $50 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 290 | $315 | $800 |
| Remote pacemaker monitoring, 90 days | 281 | $20 | $62 |
| Initial hospital admission, moderate complexity | 277 | $104 | $278 |
| Echocardiogram, transthoracic | 258 | $137 | $389 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 182 | $53 | $142 |
| Hospital follow-up visit, moderate complexity | 173 | $63 | $149 |
| Office visit, established patient, complex (40-54 min) | 160 | $133 | $310 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 152 | $26 | $71 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 144 | $2,086 | $4,827 |
| Nuclear medicine study of heart muscle blood flow by pet | 144 | $140 | $342 |
| Programming of dual lead pacemaker system | 137 | $57 | $141 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 133 | $49 | $160 |
| New patient office visit (45-59 min) | 122 | $119 | $333 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 121 | $126 | $369 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 109 | $9 | $22 |
| Hospital follow-up visit, low complexity | 91 | $40 | $82 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 84 | $19 | $53 |
| Ultrasound of leg arteries or artery grafts | 82 | $172 | $483 |
| Prothrombin time test (blood clotting) | 81 | $4 | $11 |
| Anticoagulant management of patient taking warfarin | 75 | $9 | $24 |
| Ultrasound of both sides of head and neck blood flow | 71 | $135 | $375 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 68 | $20 | $60 |
| Injection, midazolam hydrochloride, per 1 mg | 59 | $0 | $1 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 54 | $165 | $215 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 53 | $25 | $96 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 46 | $39 | $101 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 44 | $422 | $1,086 |
| Removal and replacement of dual lead permanent pacemaker | 44 | $283 | $737 |
| Ultrasound of heart, follow-up | 42 | $68 | $192 |
| Laser destruction of incompetent vein of arm or leg using imaging guidance | 35 | $731 | $2,105 |
| Ultrasound of one leg arteries or artery grafts | 35 | $89 | $286 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 32 | $89 | $226 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 29 | $299 | $839 |
| Review by radiologist of abdominal aorta image | 26 | $98 | $279 |
| Programming of multiple lead implantable defibrillator system | 26 | $79 | $195 |
| New patient office visit, complex (60-74 min) | 26 | $148 | $428 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 26 | $64 | $205 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 24 | $126 | $673 |
| Review by radiologist of arm or leg artery image | 22 | $119 | $332 |
| Programming of single lead pacemaker system | 20 | $53 | $117 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 17 | $20 | $53 |
| Programming of dual lead implantable defibrillator system | 17 | $72 | $183 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $11 | $30 |
| Ultrasound of heart with probe in esophagus, with report | 15 | $170 | $477 |
| Ultrasound of heart blood flow, valves and chambers | 15 | $39 | $103 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 15 | $18 | $48 |
| Ultrasound of one side of head and neck blood flow | 15 | $96 | $325 |
| New patient office visit (30-44 min) | 15 | $63 | $220 |
| Initial hospital admission, high complexity | 13 | $138 | $364 |
| Removal and replacement of multiple lead defibrillator | 12 | $315 | $866 |
| Insertion of heart rhythm monitor under skin | 11 | $72 | $189 |
| Removal of heart rhythm monitor from under the skin | 11 | $62 | $184 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.3% high complexity
39.6% medium
46.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$23,233
Total received (2018-2024)
Avg $3,319/year across 7 years
Top 13% in FL for cardiovascular disease
50
Companies
645
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,058 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$176 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$6,022
2023$3,449
2022$2,477
2021$2,861
2020$1,061
2019$3,256
2018$4,108
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$4,128
BIOTRONIK INC.
$3,320
Boston Scientific Corporation
$1,791
Janssen Pharmaceuticals, Inc
$1,418
Amgen Inc.
$1,353
Medtronic Vascular, Inc.
$1,298
PFIZER INC.
$979
Boehringer Ingelheim Pharmaceuticals, Inc.
$772
Novartis Pharmaceuticals Corporation
$719
E.R. Squibb & Sons, L.L.C.
$598
Cook Medical LLC
$547
SANOFI-AVENTIS U.S. LLC
$493
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$467
AngioDynamics, Inc.
$437
ShockWave Medical, Inc
$380
AstraZeneca Pharmaceuticals LP
$371
United Therapeutics Corporation
$362
LimFlow Inc.
$330
Medtronic, Inc.
$306
Amarin Pharma Inc.
$251
Merck Sharp & Dohme LLC
$239
ABIOMED
$199
BOSTON SCIENTIFIC CORPORATION
$194
Kestra Medical Technology Services, Inc.
$177
Regeneron Healthcare Solutions, Inc.
$171
Philips Electronics North America Corporation
$163
Esperion Therapeutics, Inc.
$156
Penumbra, Inc.
$138
Bayer HealthCare Pharmaceuticals Inc.
$138
Stryker Corporation
$128
Shockwave Medical, Inc
$122
Cook Incorporated
$104
Aziyo Biologics, Inc.
$103
Impulse Dynamics (USA) Inc.
$96
Novo Nordisk Inc
$85
Braemar Manufacturing, LLC
$85
ATRICURE, INC.
$83
Lexicon Pharmaceuticals, Inc.
$83
Merck Sharp & Dohme Corporation
$73
Maquet Cardiovascular U.S. Sales, L.L.C.
$65
Astellas Pharma US Inc
$64
Cardiovascular Systems Inc.
$56
Bardy Diagnostics, Inc.
$42
Siemens Medical Solutions USA, Inc.
$36
Philips North America LLC
$26
Inari Medical, Inc.
$22
iRhythm Technologies, Inc.
$18
Lilly USA, LLC
$18
Aegerion Pharmaceuticals, Inc.
$17
Elutia, Inc.
$13
Top 3 companies account for 39.8% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (5054) Geneva · (5091) Amb Mon & Diag Und · (CM9) Amb Mon & Diag Und · ANDEXXA · ATRICLIP LAA EXCLUSION SYSTEM · AURYON LASER SYSTEM 100-120 VAC · AVEIR · Acticor 7 VR-T DX · Advisa · Armada 35 percutaneous catheter · Artis one · Assure WCD · Astron; Pulsar; AstronPulsar · Azure · BIOMONITOR · BRILINTA · BioMonitor · CAMZYOS · CARDIOHELP · CONFIRM RX · COOK MEDICAL PERIPHERAL INTERVENTION · COOK MEDICAL WIRE GUIDES · COOK MEDICAL ZILVER PTX · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Claria MRI · ClosureFast · Confirm Rx · Cook Medical Stents · Cook Medical Zilver PTX · Corlanor · DYNAGEN MINI ICD VR · Diamondback Coronary · Diamondback Peripheral · ECM Patch · ELIQUIS · EMBLEM · EMBLEM SICD ELECTRODE DELIVERY SYSTEM · ENSITE PRECISION · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · EVLT · Edora · Edora 8 DR-T · Endurant · FARXIGA · FFR Link · FLOWTRIEVER CATHETER · GALLANT · GENERAL THERAPIES · GENERAL STENTS · GENERAL - THERAPIES · HawkOne · IN.PACT Admiral · INGEVITY · INVOKANA · Impella · Indigo System · Inpefa · JARDIANCE · JETI PERIPHERAL CATHETER · JOT DX · JUXTAPID · Kerendia · LATITUDE · LEQVIO · LEXISCAN · LIMFLOW SYSTEM · LINQ II · LOKELMA · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · MAKO · MERLIN@HOME · MITRACLIP · MULTAQ · Micra · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · NONE · ORENITRAM · Optimizer · Optimizer Smart System · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Penumbra System · Peripheral Orbital Atherectomy System · Pouch · RESONATE · Repatha · Reveal LINQ · Rivacor · Rivacor 7 DR-T · S · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SQ RX PULSE GENERATOR · SQ-RX PULSE GENERATOR · SQRX PULSE GENERATOR · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Solia · TRADJENTA · TURBOHAWK · TYVASO · VARITHENA · VERQUVO · VIGILANT X4 CRT-D · VYNDAQEL · Varithena Administration Pack · Vascepa · Vascular Lithotripsy · Victoza · WALLSTENT · WATCHMAN · WATCHMAN FLX · XARELTO · XXL · Xultophy 100/3.6 · ZENITH ALPHA · ZILVER PTX · ZIO XT Patch · Zero Gravity · Zilver PTX · myLUX Patient Kit with mobile device
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $261 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
53
Per 100K population
13.7
County median income
$58,535
Nearest hospital
MARION COMMUNTIY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Solanki is a electrophysiology & cardiac specialist, with above-average Medicare volume (top 9% in FL), and high industry engagement (low-engagement, top 13%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Solanki experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Solanki performed 1,860 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Solanki receive payments from pharmaceutical companies?
Yes. Dr. Solanki received a total of $23,233 from 50 companies across 645 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Solanki's costs compare to other cardiovascular diseases in Ocala?
Dr. Solanki's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Solanki) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Ocala
Browse cardiovascular diseases in Ocala ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC..
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology